Skip to content

The awakening efficacy and mechanism of transcranial direct current stimulation for patients with acute disorders of consciousness

The awakening efficacy and safety of transcranial direct current stimulation combined with standardized position transformation for patients with acute disorders of consciousness

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107933
Enrollment
Unknown
Registered
2025-08-21
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute disorders of consciousness

Interventions

tDCS combined with SPT group:tDCS combined with standardized position transformation
SPT group:standardized position transformation

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for aDOC patients: 1. The GCS scale score is 4-8 points, and the GCS sports score < 5 points; 2. The duration of consciousness disorders is 14-21 days; 3. Age range from 18-65 years old; 4. Brain CT scan shows brain injury including traumatic and non traumatic with no more than 30% of the brain lobes damaged; 5. The patient's basic vital signs are stable; 6. The patient's family members sign an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. The patient's vital signs are unstable and the condition is worsening; 2. Patients with secondary or multiple brain injuries; 3. aDOC patients caused by hypoxic encephalopathy or other viral encephalitis; 4. Patients with severe organ disorders such as heart, liver, and kidney failure; 5. The patient is currently participating in other clinical trials that may affect the evaluation of the results of this study; 6. Individuals with metal implants or implanted pacemakers in the brain are contraindicated for tDCS treatment.

Design outcomes

Primary

MeasureTime frame
coma recovery scale?revised;full outline of un-responsiveness scale;Glasgow outcome scale-Extended;Incidence and severity of adverse events;electroencephalography;functional near-infrared spectroscopy;somatosensory evoked potential;

Secondary

MeasureTime frame
Glasgow coma scale;

Countries

China

Contacts

Public ContactChengsen Jia

Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University

jasen@scu.edu.cn+86 133 9818 4656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026